Zobrazeno 1 - 10
of 39
pro vyhledávání: '"C M, Bate"'
Autor:
M. D. Taylor, C. E. Emmas, G. D. Bell, A. T. R. Axon, G. D. Kerr, G. Tildesley, J. R. B. Green, C. M. Bate
Publikováno v:
Alimentary Pharmacology & Therapeutics. 9:513-520
SUMMARY Aims: To compare the efficacy, safety and tolerability of an omeprazole/amoxycillin (OA) dual therapy Helicobacter pylori eradication regimen with an omeprazole/amoxycillin/metronidazole (OAM) triple therapy regimen. Methods: In this double-b
Publikováno v:
Alimentary Pharmacology & Therapeutics. 3:83-91
In a double-blind parallel-group study, 98 patients with symptomatic duodenal ulcer received omeprazole 20 mg o.m. and 91 cimetidine 800 mg nocte for 2 or, if then not healed, 4 weeks. After 2 weeks the healing rates on an intention-to-treat basis we
Autor:
C. M. Bate, V. McMillan Carr, P. P. C. Graziadei, H. V. B. Hirsch, A. Hughes, D. Ingle, A. G. Leventhal, G. A. Monti Graziadei, E. W. Rubel, R. Saxod, A. B. Scheibel, M. E. Scheibel, J. Silver, M. Jacobson
This preface is addressed to the reader who wishes to inquire into the prevailing concepts, hypotheses and theories about development of sensory systems and wants to know how they are exemplified in the following chapters. I believe that science is h
The management of acid-related disorders: the burden of disease and the need for effective treatment
Autor:
C M Bate
Publikováno v:
Journal of Medical Economics. 1:51-67
A large and increasing number of people suffer from acid-related disorders such as dyspepsia, gastro-oesophageal reflux disease (GORD), and peptic ulcer disease. In 1994 alone, about 2 million pati...
Autor:
P. D. I. Richardson, C. M. Bate
Publikováno v:
PharmacoEconomics. 3:94-99
Autor:
C M Bate
Publikováno v:
Gut. 43(5)
Background—Previous evaluations of the cost effectiveness of antireflux medication used in gastro-oesophageal reflux disease (GORD) have been based on results obtained in controlled clinical trials. Unfortunately such an approach does not necessari
Publikováno v:
Alimentary pharmacologytherapeutics. 13(1)
There is a need for a simple, therapeutic test that is of diagnostic value and can also provide rapid symptom relief in patients who present with classic, mild symptoms suggestive of gastro-oesophageal reflux disease (GERD), when the diagnosis is bas
Autor:
C M, Bate, J R, Green, A T, Axon, G, Tildesley, F E, Murrays, S M, Owen, C, Emmas, M D, Taylor
Publikováno v:
Alimentary pharmacologytherapeutics. 12(1)
There is documentation of the long-term use of omeprazole 10 mg o.d. in patients with reflux oesophagitis but not in the large number of gastrooesophageal reflux disease (GERD) patients without oesophagitis. There is also a paucity of data on the lon
Autor:
D. A. Watts, D.P. O'Donoghue, Roger W. Chapman, C. M. Bate, S. M. Griffin, M. W. Dronfield, J. Calam, P. W. N. Keeling, R. A. Mountford, P. D. I. Richardson, A. T. R. Axon, J. P. Crowe, M. D. Taylor
Publikováno v:
Alimentary pharmacologytherapeutics. 10(4)
Background: As many as 50% of patients with reflux symptoms have no endoscopic evidence of oesophagitis. This multicentre study was designed to assess symptom relief after omeprazole 20 mg once daily in patients with symptoms typical of gastro-oesoph
Autor:
C. M. Bate, G. Tildesley, M. D. Taylor, J. L. Martin, A. T. R. Axon, P. D. I. Richardson, G. D. Bell
Publikováno v:
Alimentary pharmacologytherapeutics. 10(4)
Aim : To determine the effect of Helicobacter pylori eradication with omeprazole and amoxycillin, with or without metronidazole, on the 12-month course of duodenal ulcer disease. Methods : In a randomized, double-blind study, conducted in 19 hospital